You must log in to view this page.

Adaptimmune Therapeutics plc – Ownership Summary

OTC: ADAPY
Share price (9/29/26): $0.03
Market cap (9/29/26): $6.891 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Google Finance
SEC EDGAR

Insider Ownership

Hill Christopher James »

12/34/56

Wood Gavin »

12/34/56

144

12/34/56

≥5% Ownership

Long Focus Capital Management, LLC »

SC 13G

SC 13G/A

SC 13G/A

SC 13G

Two Seas Capital LP »

SC 13G/A

SC 13G/A

SC 13G/A

SC 13G

Adaptimmune Therapeutics plc – Ownership Summary Watch

Search in Documents

Key Exhibits

External Links

Insider Ownership

Hill Christopher James »

Wood Gavin »

≥5% Ownership

Long Focus Capital Management, LLC »

Two Seas Capital LP »

Adaptimmune Therapeutics plc – Ownership Summary